BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15327697)

  • 1. A study of the brain structures involved in the acute effects of fluoxetine on REM sleep in the rat.
    Monti JM; Jantos H
    Int J Neuropsychopharmacol; 2005 Mar; 8(1):75-86. PubMed ID: 15327697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the 5-HT1A receptor ligands flesinoxan and WAY 100635 given systemically or microinjected into the laterodorsal tegmental nucleus on REM sleep in the rat.
    Monti JM; Jantos H
    Behav Brain Res; 2004 May; 151(1-2):159-66. PubMed ID: 15084431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of the 5-HT1A receptor agonist flesinoxan given locally or systemically on REM sleep in the rat.
    Monti JM; Jantos H
    Eur J Pharmacol; 2003 Oct; 478(2-3):121-30. PubMed ID: 14575796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of serotonin 5-HT(1B) receptor in the dorsal raphe nucleus affects REM sleep in the rat.
    Monti JM; Jantos H; Lagos P
    Behav Brain Res; 2010 Jan; 206(1):8-16. PubMed ID: 19737581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic administration and local microinjection into the central nervous system of the 5-HT(7) receptor agonist LP-211 modify the sleep-wake cycle in the rat.
    Monti JM; Leopoldo M; Jantos H
    Behav Brain Res; 2014 Feb; 259():321-9. PubMed ID: 24286819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The serotonin 5-HT7 receptor agonist LP-44 microinjected into the dorsal raphe nucleus suppresses REM sleep in the rat.
    Monti JM; Leopoldo M; Jantos H
    Behav Brain Res; 2008 Aug; 191(2):184-9. PubMed ID: 18466985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin control of sleep-wake behavior.
    Monti JM
    Sleep Med Rev; 2011 Aug; 15(4):269-81. PubMed ID: 21459634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of activation and blockade of 5-HT2A/2C receptors in the dorsal raphe nucleus on sleep and waking in the rat.
    Monti JM; Jantos H
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1189-95. PubMed ID: 16713054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dorsal raphe nucleus administration of 5-HT1A receptor agonist and antagonists: effect on rapid eye movement sleep in the rat.
    Monti JM; Jantos H; Monti D; Alvariño F
    Sleep Res Online; 2000; 3(1):29-34. PubMed ID: 11382897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased REM sleep after intra-dorsal raphe nucleus injection of flesinoxan or 8-OHDPAT: prevention with WAY 100635.
    Monti JM; Jantos H; Monti D
    Eur Neuropsychopharmacol; 2002 Feb; 12(1):47-55. PubMed ID: 11788240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of dorsal raphe nucleus serotonin 5-HT1A receptor in the regulation of REM sleep.
    Monti JM; Monti D
    Life Sci; 2000 Apr; 66(21):1999-2012. PubMed ID: 10823340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the serotonin 5-HT3 receptor in the dorsal raphe nucleus suppresses REM sleep in the rat.
    Monti JM; Jantos H
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):940-7. PubMed ID: 18295951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of the NMDA and AMPA/kainate receptors in the dorsal raphe nucleus prevents the 5-HT₃ receptor agonist m-chlorophenylbiguanide-induced suppression of REM sleep in the rat.
    Monti JM; Jantos H; Catenaccio V; Xavier S
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jul; 35(5):1341-8. PubMed ID: 21514352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microinjection of the 5-HT7 receptor antagonist SB-269970 into the rat brainstem and basal forebrain: site-dependent effects on REM sleep.
    Monti JM; Leopoldo M; Jantos H; Lagos P
    Pharmacol Biochem Behav; 2012 Aug; 102(2):373-80. PubMed ID: 22659581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WAY100635 prevents the changes induced by fluoxetine upon the 5-HT1A receptor functionality.
    Castro E; Díaz A; Rodriguez-Gaztelumendi A; Del Olmo E; Pazos A
    Neuropharmacology; 2008 Dec; 55(8):1391-6. PubMed ID: 18809415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase of waking and reduction of NREM and REM sleep after nitric oxide synthase inhibition: prevention with GABA(A) or adenosine A(1) receptor agonists.
    Monti JM; Jantos H; Monti D
    Behav Brain Res; 2001 Aug; 123(1):23-35. PubMed ID: 11377727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of systemic and local microinjection into the central nervous system of the selective serotonin 5-HT6 receptor agonist WAY-208466 on sleep and wakefulness in the rat.
    Monti JM; Jantos H; Schechter LE
    Behav Brain Res; 2013 Jul; 249():65-74. PubMed ID: 23624323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the 5-HT(7) receptor antagonist SB-269970 microinjected into the dorsal raphe nucleus on REM sleep in the rat.
    Monti JM; Jantos H
    Behav Brain Res; 2006 Feb; 167(2):245-50. PubMed ID: 16290281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The serotonergic system may be involved in the sleep-inducing action of oleamide in rats.
    Yang JY; Wu CF; Wang F; Song HR; Pan WJ; Wang YL
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):457-62. PubMed ID: 14615880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sleep and waking following microdialysis perfusion of the selective 5-HT1A receptor antagonist p-MPPI into the dorsal raphe nucleus in the freely moving rat.
    Sørensen E; Grønli J; Bjorvatn B; Bjørkum A; Ursin R
    Brain Res; 2001 Apr; 897(1-2):122-30. PubMed ID: 11282365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.